Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Payables (2016 - 2025)

Historic Payables for SRx Health Solutions (SRXH) over the last 16 years, with Q3 2025 value amounting to $2.1 million.

  • SRx Health Solutions' Payables fell 9507.08% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year decrease of 9507.08%. This contributed to the annual value of $2.1 million for FY2025, which is N/A changed from last year.
  • SRx Health Solutions' Payables amounted to $2.1 million in Q3 2025, which was down 9507.08% from $42.5 million recorded in Q2 2025.
  • SRx Health Solutions' 5-year Payables high stood at $43.6 million for Q3 2024, and its period low was $2.1 million during Q3 2025.
  • Its 5-year average for Payables is $8.8 million, with a median of $4.6 million in 2021.
  • Examining YoY changes over the last 5 years, SRx Health Solutions' Payables showed a top increase of 59538.31% in 2025 and a maximum decrease of 9507.08% in 2025.
  • SRx Health Solutions' Payables (Quarter) stood at $4.6 million in 2021, then crashed by 35.6% to $2.9 million in 2022, then skyrocketed by 141.81% to $7.1 million in 2023, then plummeted by 55.75% to $3.1 million in 2024, then tumbled by 31.56% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $42.5 million for Q2 2025, and $4.4 million during Q1 2025.